Insiders · Profile

Hurvitz Eli

Director at Protalix BioTherapeutics. Filing since 12 Nov 2009. CIK 0001385120

Company

Date

Role

Action

Shares

Amount

Of holding

PLX Protalix BioTherapeutics, Inc.

12 Nov 2009

Director

Sold, plan not stated

1,371,967

$13.91M

47.5%

1 decision on file.